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1. Introduction 
In [ 1,2] a highly antigenic fibroblast surface glyco- 
protein (FSG) was shown to be an integral membrane 
protein of M, 150 000 under denaturating conditions. 
FSG was not released from the cell surface by trypsin 
treatment, while papain solubilized a 140 000 MI 
hydrophilic part of the molecule, which was also 
present intracellularly. The antigen was expressed 
only by a few cultured human cell lines, all of mesen- 
chymal origin [ 21, but in vivo, in addition to the 
fibroblasts of most tissues, the brush border of kid- 
ney and intestine, the bile canaliculi in liver and the 
acinar cells of pancreas stained selectively with a 
monospecific anti-FSG antiserum [3]. Since a variety 
of hydrolases (aminopeptidase, dissacharidases, alka- 
line phosphatase and y-glutamyltransferase), probably 
involved in the active transport of a number of 
metabolites, have been localized in these sites [4], we 
have tested the hypothesis that FSG might be one of 
these surface enzymes. 
From a comparative literature study [S] and from 
this investigation it can be concluded that the fibro- 
blast surface glycoprotein is an aminopeptidase M. 
2. Materials and methods 
2 .l . Cell lines and cell culture 
Diploid human skin fibroblasts [6], MC63 cells, 
derived from a human osteosarcoma [7], CCL30 
(squamous cell carcinoma), CCL1 21 (fibrosarcoma), 
CCL1 36 (rhabdomyosarcoma) and CCL1 38 (pharynx 
carcinoma), obtained from the American Type Cul- 
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ture Collection (Rockville, MD), and endothelial cells 
were cultured as in [6]. Peripheral lymphocytes, 
normal serum and serum from a patient with liver 
cirrhosis were obtained from the Red Cross Blood 
Centre, Leuven. 
2.2. Preparation of cell and tissue extracts 
CeU extracts were obtained by sonication of the 
cell pellet in 75 mM Verona1 buffer (PH 8.6) contain- 
ing 2% of the non-ionic detergent Berol (Berol Kemi 
AB, Sweden). Human kidney and liver were obtained 
from autopsies performed within 6 h after death, 
when no primary renal or liver disease was apparent. 
For kidney, the cortex was separated from the 
medulla. Homogenization was performed in a Potter- 
Elvehjem homogenizer with a Teflon pestle in 75 mM 
Verona1 (pH 8.6) containing 2% Berol (tissue/buffer, 
1:3, w/v), followed by sonication. Unsoluble material 
was removed by centrifbgation. 
2.3. Enzyme assay 
Aminopeptidase activity was determined spectro- 
photometrically by measuring the rate of liberation 
of p-nitroaniline and fl-naphthylamine from amino 
acid derivatives at 410 nm and 340 nm, respectively. 
Activities on cell homogenates were determined in 
50 mM Tris-HCl (pH 7.3) containing 1 mM substrate 
at 25°C. In these conditions the rate of substrate 
hydrolysis increased linearly in function of time and 
enzyme concentration. Extinction values measured 
after 30 min were corrected for turbidity and spon- 
taneous substrate hydrolysis. One unit of enzyme 
activity is defined as the amount of enzyme hydro- 
lyzing 1 pmol substratelmin using the extinction 
coefficients 8850 M-' . cm-’ and 1780 M-’ . cm-’ for 
p-nitroaniline and P-naphthylamine, respectively. 
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Kinetic constants were determined from plots of 
1 /V vs 1 /[S]. Five different substrate concentrations 
were used in each experiment. All enzyme substrates 
were purchased from Sigma Chemical Co. (St Louis, 
MO). 
The inhibitory effect of EDTA and 1 ,I O-phenan- 
throline was assayed by incubating cell homogenates 
for 20 h at 5°C with different concentrations of the 
chelator before enzymatic activity was measured. 
Protein was measured as in [ 81 using bovine serum 
albumin as standard. 
2.4. Immunoelectrophoresis 
Crossed and rocket immunoelectrophoresis were 
done as in [1,9] with monospeci~c anti-FSG anti- 
bodies [2] in the immunogel. Staining of immuno- 
precipitates for aminopeptidase activity was per- 
formed on wet gels by coupling @raphtylamine, the 
product of splitting alanine-~-naphthyIamide, with 
fast blue B salt according to [lo]. 
3. Results 
3.1 . Immunoprecipitation of aminopeptidase activity 
with anti-F&G an t&rum 
The typical polymorphic FSG immunoprecipitate 
obtained in crossed immunoelectrophoresis with the 
monospecific anti-FSG antiserum (fig.1 A), exhibited 
aminopeptidase activity when stained with alanine- 
/3-naphthylamide (fig.1 B). To further substantiate 
that FSG was identical to aminopeptidase, enzymatic 
activity was measured after double immunoprecipita- 
tion of the FSG antigen. Fibroblast homogenates 
were immunoprecipitated with anti-FSG antiserum 
followed by swine anti-rabbit IgG (Dakopatts, 
Sweden). No residual aminopeptidase activity was 
observed in the supernatant, whether alanine-- 
/l-naphthylamide or alanine-p-nitroanilide was used 
as substrate. Control samples receiving non-immune 
IgG instead of anti-FSG had the same aminopeptidase 
activity before and after the antibody treatment. 
3.2. Characteristics offibroblast aminopeptidase 
The fibroblast enzyme showed the highest activity 
towards alanine-~-naphthylamide (table 1). The val- 
ues obtained with alanine- and leucine-p-nitroanilide 
were, respectively, 26% and 43% lower. The cu-glu- 
tamic acid substrate was hydrolyzed at a very slow 
rate. A Lineweaver-Burk plot of assays performed at 
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Fig.1. Crossed immunoelectrophoresis of human skin fibro- 
blasts (A,B), human kidney K) and human liver (D). The 
immunogel contained anti-FSG antibodies (15 Hg lgC/cmZ): 
first dimension, 90 min at JO V/cm (anode to the left); sec- 
ond dimension, 16 h at 4 V/cm (anode to the top); (A,C,D) 
the immunoprecipitates were stained with Coomassie brilliant 
blue; (B) the plate was stained for aminopeptidase activity 
with alanine-P-naphthylamide as substrate. 
pH 7.3 and 25’C using substrate concentrations rang- 
ing from 0.08-l mM indicated an app. Km value of 
0.62 mM for alanine-p-nitroanilide. ~ucinamide 
inhibited the activity of the enzyme towards alanine-- 
p-nitroanilide competitively with a Ki-value of 
3.4 1 mM indicating that leucinamide was a poor sub- 
strate. The enzynlatic activity measured in Tris-HCI 
buffer exhibited an optimum near pH 8.0 with a 
Table 1 
Arninopeptidase activity in human fibroblasts, measured with 
different substrates 
Substrate Aminopeptidase activity 
mu/l 0’ cells Relative % 
Lalanine-P-naphthylamide 66.3 100 
L-alanme-p-nitroanilide 48.8 14 
L-~euc~e-~-nitroan~de 37.6 57 
La-glutamic acid-~-nitroan~ide 0.2 0.5 
Confluent fibroblast cell layers were dissociated with trypsin 
and aminopeptidase activity was measured on cell homoge- 
nates as in section 2. Each figure represents the average of 
duplicate assays 
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Table 2 
Quantitative screening of human cells and tissues for the 
presence of aminopeptidase and FSG 
Tissue Aminopeptidase FSGb 
activitya 
Kidney cortex 47.3 23.5 
Normal skin fibroblasts (NHF) 41.3 29.5 
Fibrosarcomaderived cells 
(CCL1 21) 38.0 24.0 
Osteosarcoma-derived cells 
(MG63) 20.3 15.0 
Liver 15.2 14.5 
Endothelial cells 13.8 9.0 
Embryonal rhabdomyosarcoma- 
derived cells (CCL1 36) 7.0 2.5 
Pharynx carcinomaderived 
cells (CCL1 38) 6.6 _c 
Peripheral ymphocytes 5.9 1.5 
Squamous cell carcinoma- 
derived cells (CCL30) 3.6 _c 
Serum from patient with 
liver cirrhosis 2.9 1.5 
Normal human serum 1.6 _c 
a Aminopeptidase activities towards alanme-p-nitroanilide 
are expressed in mU/mg total protein 
b Amounts of FSG are expressed as the height (mm) of the 
rockets obtained in rocket immunoelectrophoresis with the 
anti-FSG antiserum 
’ Samples with no visible immunoprecipitates formed in 
rocket immunoelectrophoresis 
broad peak extending from pH 7.0-8.5. EDTA and 
1 ,lO-phenanthroline, inhibitory only after preincu- 
bation, showed maximal inhibition at 0.2 mM EDTA 
(93%) or 1 mM 1 ,I 0-phenanthroline (97%). 
3 3. Screening oj‘different human cell lines, tissues 
and sera 
The amount of FSG present in human cells of dif- 
ferent origin was quantitated both by rocket immu- 
noelectrophoresis and by enzyme activity towards 
alanine-p-nitroanilide. For comparison, kidney cor- 
tex and liver, with known high levels of activity, were 
assayed in the same way. The highest activity was 
found in kidney cortex, followed by skin fibroblasts 
and the fibrosarcoma-derived cell line CCL1 21 
(table 2). Peripheral blood lymphocytes and normal 
serum had low activities. Serum of a patient with liver 
cirrhosis contained twice as much aminopeptidase 
activity as normal serum. By rocket immunoelectro- 
phoresis the same general order was obtained. Overall, 
a good correlation was obtained between the enzy- 
matic activity and the amount of FSG quantitated by 
rocket immunoelectrophoresis (r = 0.96). Although 
the aminopeptidases from liver and kidney were 
recognized by the anti-FSG antiserum, their immuno- 
precipitation patterns in crossed immunoelectropho- 
resis were not completely identical to the pattern 
obtained with the fibroblast enzyme (fig.lC,D). 
4. Conclusion 
Aminopeptidase M (EC 3.4.11.2) is a membrane- 
associated enzyme that acts upon peptides as well as 
upon chromogenic substrates. It is distinct from clas- 
sical leucine aminopeptidase (EC 3.4.11 .I) by virtue 
of differences in solubility, substrate specificity and 
metal ion requirements [ 51. The molecular properties 
and mode of membrane insertion of aminopepti- 
dase M from intestinal and renal brush border mem- 
branes have been well documented [ 11 ,I 2,131. 
Here, the 150 000 M,, highly antigenic surface 
glycoprotein of human fibroblast [ 1,2] was shown to 
exhibit aminopeptidase activity. The enzymatic activ- 
ity associated with the membrane component acted 
preferentially on alanine-derivatives of chromogenic 
substrates indicating that the nzyme is of the micro- 
somal type (aminopeptidase M) [ 51. 
The presence of an antigen on fibroblasts, reacting 
with anti-intestinal aminopeptidase has been described 
[ 141. Monospecific antibodies prepared against the 
fibroblast antigen showed cross-reaction with liver 
and kidney aminopeptidase. The tissue-derived 
enzymes, however, did not give an identical immuno- 
precipitation pattern as the tibroblast enzyme in CIE. 
In intestine, liver and kidney, high activity of ami- 
nopeptidase in the brush border has been correlated 
with the intense transport which occurs at these sites. 
For fibroblasts and other mesenchymal cells, a ration- 
ale for the presence of large amounts of this enzyme 
in their plasma membrane remains to be determined. 
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